SEC Form 4 · accession 0001209191-15-066029
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joshua S Boger
Director
Period of report
Aug 12, 2015
Accepted (ET)
Aug 14, 2015 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 12, 2015 | M | 10,400 | $35.64 | A | 355,684 | D | |
| Common StockF2,F3 | Aug 12, 2015 | S | 1,300 | $133.53 | D | 354,384 | D | |
| Common StockF2,F4 | Aug 12, 2015 | S | 1,700 | $134.54 | D | 352,684 | D | |
| Common StockF2,F5 | Aug 12, 2015 | S | 2,800 | $135.48 | D | 349,884 | D | |
| Common StockF2,F6 | Aug 12, 2015 | S | 1,700 | $136.48 | D | 348,184 | D | |
| Common StockF2,F7 | Aug 12, 2015 | S | 2,600 | $137.50 | D | 345,584 | D | |
| Common StockF2,F8 | Aug 12, 2015 | S | 300 | $138.07 | D | 345,284 | D | |
| Common Stock | holding | — | — | — | 13,286 | I | 401(k) | |
| Common Stock | holding | — | — | — | 122,700 | I | Common Stock held in trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F9 | $35.64 | Aug 12, 2015 | M | 10,400 | D | — | Feb 1, 2016 | Common Stock | 10,400 | 250,400 | D |
Explanation of responses
- F1Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- F2Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F3Open market sales reported on this line occurred at a weighted average price of $133.53 (range $133.00 to $133.85).
- F4Open market sales reported on this line occurred at a weighted average price of $134.54 (range $134.00 to $134.97).
- F5Open market sales reported on this line occurred at a weighted average price of $135.48 (range $135.00 to $135.86).
- F6Open market sales reported on this line occurred at a weighted average price of $136.48 (range $136.02 to $136.90).
- F7Open market sales reported on this line occurred at a weighted average price of $137.50 (range $137.04 to $137.85).
- F8Open market sales reported on this line occurred at a weighted average price of $138.07 (range $138.05 to $138.11).
- F9Fully vested.